By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Cardiac stressing agents > Persantine > Persantine Side Effects
Cardiac stressing agents

Persantine Side Effects

Note: This document contains side effect information about dipyridamole. Some dosage forms listed on this page may not apply to the brand name Persantine.

Applies to dipyridamole: solution, tablet.

Serious side effects of Persantine

Along with its needed effects, dipyridamole (the active ingredient contained in Persantine) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor as soon as possible if any of the following side effects occur while taking dipyridamole:

Rare

  • Chest pain
  • gallstones
  • tightness or swelling of neck
  • yellow eyes or skin

Other side effects of Persantine

Some side effects of dipyridamole may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Abdominal or stomach cramps
  • diarrhea
  • dizziness or lightheadedness

Less common

  • Flushing
  • headache
  • nausea or vomiting
  • weakness

Rare

  • General discomfort and/or unusual tiredness or weakness
  • hair loss
  • joint pain or swelling
  • muscle pain
  • runny nose
  • sneezing

For Healthcare Professionals

Applies to dipyridamole: compounding powder, intravenous solution, oral tablet.

General

The most frequent adverse reactions were chest pain/angina pectoris, electrocardiographic changes (mostly ST-T changes), headache, and dizziness.[Ref]

Cardiovascular

Very common (10% or more): Chest pain/angina pectoris (19.7%), electrocardiographic changes (15.9%)

Common (1% to 10%): Electrocardiographic abnormalities/ST-T changes, electrocardiographic abnormalities/extrasystoles, hypotension, flushing, electrocardiographic abnormalities/tachycardia, blood pressure lability, hypertension, angina pectoris, bleeding

Uncommon (0.1% to 1%): Myocardial infarction, electrocardiographic abnormalities unspecified, arrhythmia unspecified, palpitation, ventricular tachycardia, bradycardia, atrioventricular block, orthostatic hypotension, atrial fibrillation, supraventricular tachycardia

Rare (0.01% to 0.1%): Fatal myocardial infarction, nonfatal myocardial infarction, ventricular arrhythmia unspecified, heart block unspecified, cardiomyopathy, intermittent claudication

Very rare (less than 0.01%): Asystole, sustained ventricular tachycardia or ventricular fibrillation

Frequency not reported: Bleeding during or after surgery, cardiac death, ventricular fibrillation, symptomatic ventricular tachycardia, sinus node arrest, sinus node depression, conduction block, tachycardia, post procedural hemorrhage, operative hemorrhage, cardiac arrest, sinus arrest

Postmarketing reports: Palpitation[Ref]

Respiratory

Common (1% to 10%): Dyspnea

Uncommon (0.1% to 1%): Severe bronchospasm, pharyngitis, bronchospasm, hyperventilation, rhinitis

Rare (0.01% to 0.1%): Dysphonia, coughing, pleural pain

Very rare (less than 0.01%): Pulmonary edema

Frequency not reported: Laryngospasm

Postmarketing reports: Larynx edema[Ref]

Nervous system

Very common (10% or more): Headache (up to 37.2%), dizziness (up to 30.1%)

Common (1% to 10%): Paresthesia

Uncommon (0.1% to 1%): Hypoesthesia, hypertonia, tremor, tinnitus, dysgeusia

Rare (less than 0.1%): Abnormal coordination, somnolence, migraine, vertigo, transient ischemic attack

Frequency not reported: Stroke, transient cerebral ischemia, seizures, cerebrovascular accident, syncope, cerebral seizure/grand mal seizure[Ref]

Gastrointestinal

Very common (10% or more): Dyspepsia (up to 16.6%), diarrhea (up to 15.4%), nausea (up to 14.8%), gastric pain (up to 14.5%)

Common (1% to 10%): Abdominal distress, vomiting

Uncommon (0.1% to 1%): Dry mouth, abdominal pain, flatulence, eructation

Rare (less than 0.1%): Dysphagia, tenesmus

Frequency not reported: Gastroduodenal ulcer[Ref]

Other

Common (1% to 10%): Pain unspecified, fatigue

Uncommon (0.1% to 1%): Asthenia, malaise, earache

Rare (less than 0.1%): Death, any complication[Ref]

Musculoskeletal

Common (1% to 10%): Myalgia

Uncommon (0.1% to 1%): Back pain, arthralgia, rigor

Rare (less than 0.1%): Leg cramping

Postmarketing reports: Arthritis[Ref]

Dermatologic

Common (1% to 10%): Rash

Uncommon (0.1% to 1%): Diaphoresis

Frequency not reported: Pruritus, urticaria

Postmarketing reports: Alopecia[Ref]

Immunologic

Uncommon (0.1% to 1%): Hypersensitivity reaction

Frequency not reported: Anaphylactoid reaction, angioedema

Postmarketing reports: Allergic reaction, urticaria, pruritus, dermatitis, rash[Ref]

Psychiatric

Uncommon (0.1% to 1%): Nervousness/anxiety

Rare (less than 0.1%): Depersonalization[Ref]

Ocular

Uncommon (0.1% to 1%): Vision abnormalities unspecified

Rare (less than 0.1%): Eye pain[Ref]

Local

Uncommon (0.1% to 1%): Injection site reaction unspecified, injection site pain[Ref]

Metabolic

Rare (less than 0.1%): Edema, appetite increased, thirst[Ref]

Endocrine

Rare (less than 0.1%): Breast pain[Ref]

Genitourinary

Rare (less than 0.1%): Perineal pain[Ref]

Renal

Rare (less than 0.1%): Renal pain[Ref]

Hematologic

Frequency not reported: Thrombocytopenia, anemia[Ref]

Hepatic

Frequency not reported: Liver dysfunction

Postmarketing reports: Hepatitis, cholelithiasis[Ref]

Hypersensitivity

Postmarketing reports: Rash, urticaria, severe bronchospasm, angioedema[Ref]

Share this Article
Latest News
Medical News

Seed oils: Omega-6 fatty acids may lower diabetes, heart disease risk

Jun 01, 2025
Type 2 diabetes: Sugary drinks may significantly raise risk
COVID-19: Who do the new vaccine guideline changes affect?
Vitamin D supplements may help slow down aging by 3 years
Aging: Exercise timing, consistency can affect heart and lung fitness
Heart health: Exercise not enough to offset effects of poor sleep
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by